萬凱新材(301216.SZ):公司作為領投人之一參與了靈心巧手PRE-A輪融資
格隆匯6月19日丨萬凱新材(301216.SZ)在投資者互動平台表示,公司作為領投人之一參與了靈心巧手PRE-A輪融資,投後股權佔比8.2%,並擁有一名董事席位。公司本次投資,不僅是看好人形機器人賽道,更希望藉助和靈心巧手的合作,與之共同研發和探索公司聚酯新材料產品及其他輕量化高性能材料產品在人形機器人中應用的可能性,並協助靈心巧手在杭州及周邊落地新產能。公司亦期待能以此為契機,與包括螞蟻公司在內的其他優秀投資人有更多的合作機會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.